Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
BMTI BioMimetic Therapeutics, Inc. Receives Approval to Commercialize Augment(R) Bone Graft in Australia
FRANKLIN, Tenn., Oct 19, 2011 (BUSINESS WIRE) -- BioMimetic Therapeutics, Inc. BMTI +18.00% today announced that the Therapeutic Goods Administration (TGA) has approved the Company's medical device application for Augment(R) Bone Graft clearing the way for commercialization of the product in Australia and its listing on the Australian Register of Therapeutic Goods (ARTG). Based on the clinical data from the North American pivotal trial and Canadian registration trial evaluating Augment Bone Graft, the product has been approved in Australia for use as an alternative to autograft, the current gold standard in bone grafting, in hindfoot and ankle fusion procedures.
"Approval of Augment Bone Graft by another major regulatory agency, such as the TGA, marks a significant achievement in BioMimetic's global product development program and further validates our technology, clinical data and ability to gain regulatory approvals," said Dr. Samuel Lynch, president and CEO of BioMimetic Therapeutics. "Given that obtaining autograft often requires a second surgical procedure, increasing the pain and potential for complications for the patient, and that Augment will be the first alternative approved in foot and ankle fusion surgery with large, randomized controlled clinical data, we are optimistic that Augment will find broad support from Australian hospitals, surgeons and patients alike. We are completing the final steps for pricing and reimbursement and expect a full launch of the product in the first quarter of 2012."
IRE 6.90
IRE nice intraday bounce 5.89 to 6.62 currently, lowish float after R/S
http://www.bloomberg.com/news/2011-10-17/bank-of-ireland-rises-after-selling-5-billion-euros-of-loans.html
IRE low 6s....looking interesting
IRE first day of R/S, down 20%
GLGL new HOD
Cantor Fitzgerald Upgrades First BanCorp (FBP) to Hold, Watch for Doral Financial (DRL) Acquisition
October 11, 2011 12:49 PM EDT
Cantor Fitzgerald upgraded shares of First BanCorp (NYSE: FBP) to a Hold rating from its previous rating of Sell, but cut its price target from $3.50 to $3.25.
Management has recently announced that the company paid back all of its TARP loan. The firm notes that the company now has a healthy 12.8 percent ratio of Tier 1 Common to Risk-Weighted Assets and a tangible book value of about $6.50 per share.
The firm also highlights that its new price target reflects a lower multiple on its peers. Cantor Fitzgerald also pointed out how stund the firm was to hear that the bank appoint Roberto Herencia as non-executive chairman of its board due to his past record.
An analyst at Cantor Fitzgerald comments, "First BanCorp's re-capitalization should assure its survival, but that is not necessarily a good thing, in our view, for any of the still-too-many survivors in over-banked Puerto Rico. We would view an acquisition of Doral Financial (NYSE: DRL) as a good use of First BanCorp's "excess capital," though it is unclear to us whether a deal could be achieved."
For more ratings news on First BanCorp click here and for the rating history of First BanCorp click here.
Shares of First BanCorp closed at $3.00 yesterday, with a 52 week range of $0.24-$7.50.
AONE new hOD
GLGL up 13% GLG Life Tech Corporation Responds to Unfounded Allegations
VANCOUVER, British Columbia, Oct 11, 2011 (GlobeNewswire via COMTEX) -- GLG Life Tech Corporation GLGL +15.00% CA:GLG +6.90% ("GLG" or the "Company"), the vertically-integrated leader in the agricultural and commercial development of high quality stevia and all-natural and zero-calorie food and beverage products, provides a response to various unfounded allegations in connection with the Company's global stevia business and AN0C joint venture operations.
The Company has become aware of certain allegations made against it in an article dated October 7, 2011 published on the GeoInvest website in the United States. Generally, the allegations claim that the Company's 2011 financial statements may have been misrepresented and that the Company failed to provide adequate disclosure surrounding its operational activities.
While the Company does not typically respond to rumors or allegations raised in the market, the Company believes it is appropriate to respond to these allegations. The Company unequivocally denies that the Company's previously filed financial statements were misrepresented and believes it has properly and accurately disclosed the nature of its business and operations. The article contains a number of allegations regarding specific operational matters that the Company believes are either wholly inaccurate or misleading.
As stated in the Company's press release issued October 6, 2011, the Company remains confident in its business strategy, its growth opportunities, its people and the progress it is making with both its global stevia business and the AN0C all-natural sweetened zero-calorie products in China.
NFLX 117
ILMN gap up Monday?
LOD for CLWR 1.32 - also the 52 week low....
getting interesting. Last time the CEO bought heavily at these levels a couple months ago
They aren't bankrupt.
Doral Financial (DRL) Shares Upgraded to a “Outperform” Rating by Zacks Investment Research Analysts.
Doral Financial (NYSE: DRL) was upgraded by equities research analysts at Zacks Investment Research from a “neutral” rating to an “outperform” rating in a research note issued to investors on Wednesday.
Nice close DRL.
Market cap currently at .27 is $13 million only.
GLTA
PEIX
Patience payed off in the past.... will see if she can do it again GLTU
Don't understand the selling pressure on DRL....anyone know more details?
VVTV lod 2.25 - good for a trade, on watch!
FRZ down 26%+ on delisting warning....
low float
DALLAS, Sept. 27, 2011 /PRNewswire/ -- Reddy Ice Holdings, Inc. (NYSE: FRZ) ("Reddy Ice" or the "Company") announced today that the Company had been notified by NYSE Regulations, Inc. that it is not in compliance with one of the continued listing standards of the New York Stock Exchange (the "NYSE").
Reddy Ice is considered below the continued listing criteria established by the NYSE because the Company's total market capitalization has been less than $50 million over a consecutive 30 trading-day period and its last reported shareholders' equity was less than $50 million.
In accordance with NYSE procedures, Reddy Ice has 45 days from the receipt of the notice to submit a plan to the NYSE demonstrating how it intends to comply with the NYSE's continued listing standards within 18 months. Upon receipt of the Company's plan, the NYSE will review and determine whether the Company has made a reasonable demonstration of its ability to come into conformity with the relevant standards within the 18 month period. The NYSE will either accept the plan, at which time the Company will be subject to ongoing monitoring for compliance with this plan, or the NYSE will not accept the plan and the Company will be subject to suspension and delisting proceedings. As required by the NYSE's rules, the Company plans to notify the NYSE within 10 days of receipt of the non-compliance notice of the Company's intent to submit a plan to remedy its non-compliance.
The Company's common stock remains listed on the NYSE under the symbol "FRZ," but will be assigned a ".BC" indicator by the NYSE to signify that the Company is not currently in compliance with the NYSE's continued listing standards. The Company is required to maintain compliance with other applicable NYSE continued listing requirements, including the minimum global market capitalization standard, which requires the Company to maintain an average global market capitalization of at least $15 million over a consecutive 30 trading-day period. Failure to maintain compliance with this requirement would result in the NYSE promptly initiating suspension and delisting procedures. On September 26, 2011, Reddy Ice's common stock had a closing price of $1.63 per share, equating to a market capitalization of approximately $38.1 million.
FRZ down 26%+ on delisting warning....
low float
DALLAS, Sept. 27, 2011 /PRNewswire/ -- Reddy Ice Holdings, Inc. (NYSE: FRZ) ("Reddy Ice" or the "Company") announced today that the Company had been notified by NYSE Regulations, Inc. that it is not in compliance with one of the continued listing standards of the New York Stock Exchange (the "NYSE").
Reddy Ice is considered below the continued listing criteria established by the NYSE because the Company's total market capitalization has been less than $50 million over a consecutive 30 trading-day period and its last reported shareholders' equity was less than $50 million.
In accordance with NYSE procedures, Reddy Ice has 45 days from the receipt of the notice to submit a plan to the NYSE demonstrating how it intends to comply with the NYSE's continued listing standards within 18 months. Upon receipt of the Company's plan, the NYSE will review and determine whether the Company has made a reasonable demonstration of its ability to come into conformity with the relevant standards within the 18 month period. The NYSE will either accept the plan, at which time the Company will be subject to ongoing monitoring for compliance with this plan, or the NYSE will not accept the plan and the Company will be subject to suspension and delisting proceedings. As required by the NYSE's rules, the Company plans to notify the NYSE within 10 days of receipt of the non-compliance notice of the Company's intent to submit a plan to remedy its non-compliance.
The Company's common stock remains listed on the NYSE under the symbol "FRZ," but will be assigned a ".BC" indicator by the NYSE to signify that the Company is not currently in compliance with the NYSE's continued listing standards. The Company is required to maintain compliance with other applicable NYSE continued listing requirements, including the minimum global market capitalization standard, which requires the Company to maintain an average global market capitalization of at least $15 million over a consecutive 30 trading-day period. Failure to maintain compliance with this requirement would result in the NYSE promptly initiating suspension and delisting procedures. On September 26, 2011, Reddy Ice's common stock had a closing price of $1.63 per share, equating to a market capitalization of approximately $38.1 million.
In January
VVTV green 2.85 x 2.86
VVTV looking for entry, bounces hard
$3 price target - a bit ambitious in my opinion...but back to a buck possible
PEIX up 20%
Zacks upgrades PEIX to "outperform" from neutral with $3 price target. Currently trading at .27
FWIW
Zacks upgrades PEIX to "outperform" with $3 price target.
Yep, horrible close. All markets tanked end of day, and futures look bad so far. DRL in better shape but the pps is back to where it was two qtrs ago. Getting way oversold and thrown out with the "bathwater" imo.
Zacks upgrades PEIX to "outperform" with $3 price target.
Oh okay, yes this makes sense. It will move easily north once the overreaction to the delisting warning is over....They have plenty of time to get over a dollar.
DRL is quiet right now, but imo 1.25 not a bad entry here today
What do you mean by 10/2 PR?
NEPH trending up with recent 510k application
I believe so, but volume is pretty low the last couple days, so I don't think that is the entire reason. Share structure relatively low given below .30 price.... it's going to bounce again, just looking for the best entrance price which may be upcoming soon. Wasn't able to grab the .25 Monday
yep, watching for entry - lol?
Been following and looking to enter...watching PEIX, getting interesting imo
PEIX .2762 x .279
PEIX below .28